NewslettersImmune Regulation NewsUncategorizedTargeting the PSGL-1 Immune Checkpoint Promotes Immunity to PD-1 Resistant MelanomaBy Justin.choi - March 21, 2022026Using an aggressive melanoma tumor model, the authors targeted PSGL-1 in tumor-bearing mice and found increased effector CD4+ and CD8+ T cell responses and decreased regulatory T cells in tumors.[Cancer Immunology Research] 6445212 BBBBBBBB items 1 apa 0 default asc 1 173109 https://www.stemcellsciencenews.com/wp-content/plugins/zotpress/Abstract